Galapagos | GLPG - Ordinary Share Capital

Stock Price
25.60
Daily Change
-0.34 -1.31%
Monthly
-9.86%
Yearly
15.94%
Q2 Forecast
24.72

Galapagos reported EUR65.9M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 206K Dec/2025
Biogen USD 146.7M 200K Sep/2025
Genmab DKK 61.62M 52K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
GRIFOLS EUR 680.58M 846K Dec/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Merck EUR 434.78M 0 Dec/2025
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 190.36M 365.15K Dec/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025